Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03736759 · ClinicalTrials.gov registry record · NA
Resistance Exercise to Improve Flu Vaccine for Older Adults
A NA study of Influenza, Human, sponsored by University of Houston.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT03736759 is a NA study of Influenza, Human that has completed, run by University of Houston. The registered enrollment target is 29 participants, below the 16,222-participant average among 18 other Influenza, Human trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03736759, a NA study of Influenza, Human, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates whether resistance exercise will improve immune responses to the seasonal influenza vaccine in older adults. One third of the participants will perform exercise in the arm that receives the vaccine, one third of the participants will perform the same exercise in the arm that does not receive the vaccine, and one third will only receive the vaccine.
Conditions Studied
Interventions
- BEHAVIORAL Exercise
Study Locations (1)
Texas
- University of Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2018-10-08 |
| Est. Completion | 2021-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03736759
The ClinicalTrials.gov registry entry for NCT03736759 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 16,222-participant average among 18 other Influenza, Human trials with a reported enrollment target (100% lower). The listed sponsor is University of Houston, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Influenza, Human appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.
NCT03736759 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03736759 about?
NCT03736759 is a clinical study titled "Resistance Exercise to Improve Flu Vaccine for Older Adults". This study evaluates whether resistance exercise will improve immune responses to the seasonal influenza vaccine in older adults. One third of the participants will perform exercise in the arm that receives the vaccine, one third of the participants will perform the same exercise in the arm that doe...
What is the current status of trial NCT03736759?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2018-10-08. Estimated completion is 2021-04-01.
What conditions does trial NCT03736759 study?
This clinical trial studies the following conditions: Influenza, Human.
What interventions are being tested in trial NCT03736759?
The interventions under investigation include: Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT03736759?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03736759 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza, Human
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mail Outreach To Increase Vaccination Acceptance Through Engagement
COMPLETED · NA
-
A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above
RECRUITING · Phase 2
-
Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults
RECRUITING · Phase 4
-
Flu Infection at UPHS
RECRUITING
-
A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older
ACTIVE NOT RECRUITING · Phase 2
-
A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.